Autologous Chondrocyte Implantation in the Patellofemoral Joint
1 other identifier
observational
35
1 country
1
Brief Summary
The purpose of this study is to measure the outcomes of patients who have articular cartilage lesions in the patellofemoral joint and are treated with the Autologous Chondrocyte Implantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 1995
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1995
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedSeptember 21, 2005
December 1, 2004
September 13, 2005
September 13, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Carticel Implantation of the patella and/or trochlear lesion. Patients who have reached their two-year follow-up date. All patients included in sequential order.
You may not qualify if:
- Patients that have had a microfracture in the knee joint at the same time as Carticel Implantation.
- Patients that have implantable lesions other than the patella and trochlea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Orthopaedic Research Foundationlead
- Genzyme, a Sanofi Companycollaborator
Study Sites (1)
Orthopaedics Indianapolis
Indianapolis, Indiana, 46237, United States
Related Publications (1)
Minas T, Bryant T. The role of autologous chondrocyte implantation in the patellofemoral joint. Clin Orthop Relat Res. 2005 Jul;(436):30-9. doi: 10.1097/01.blo.0000171916.40245.5d.
PMID: 15995417BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Jack Farr, MD
Orthopaedic Research Foundation, Inc.
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
January 1, 1995
Study Completion
August 1, 2005
Last Updated
September 21, 2005
Record last verified: 2004-12